Patrick Harrison Carroll - Feb 28, 2022 Form 4 Insider Report for Hims & Hers Health, Inc. (HIMS)

Role: Director
Signature: /s/ Soleil Boughton, Attorney-in-Fact
Stock symbol: HIMS
Transactions as of: Feb 28, 2022
Transactions value $: -$17,772
Form type: 4
Date filed: 3/2/2022, 03:46 PM
Previous filing: Feb 28, 2022
Next filing: Aug 11, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	HIMS	Class A Common Stock	Options Exercise	$76.8K	+43.9K	+210.39%	$1.75^*	64.7K	Feb 28, 2022	Direct
transaction	HIMS	Class A Common Stock	Options Exercise	$100K	+41.2K	+63.61%	$2.43	106K	Feb 28, 2022	Direct
transaction	HIMS	Class A Common Stock	Options Exercise	$43.3K	+17.8K	+16.81%	$2.43	124K	Feb 28, 2022	Direct
transaction	HIMS	Class A Common Stock	Options Exercise	$211K	+86.8K	+70.18%	$2.43	211K	Feb 28, 2022	Direct
transaction	HIMS	Class A Common Stock	Sale	-$449K	-86.8K	-41.24%	$5.17	124K	Feb 28, 2022	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	HIMS	Stock Option (right to buy)	Options Exercise	$0	-43.9K	-100%	$0.00^*	0	Feb 28, 2022	Class A Common Stock	43.9K	$1.75	Direct	F2
transaction	HIMS	Stock Option (right to buy)	Options Exercise	$0	-41.2K	-100%	$0.00^*	0	Feb 28, 2022	Class A Common Stock	41.2K	$2.43	Direct	F3
transaction	HIMS	Stock Option (right to buy)	Options Exercise	$0	-17.8K	-100%	$0.00^*	0	Feb 28, 2022	Class A Common Stock	17.8K	$2.43	Direct	F3
transaction	HIMS	Stock Option (right to buy)	Options Exercise	$0	-86.8K	-100%	$0.00^*	0	Feb 28, 2022	Class A Common Stock	86.8K	$2.43	Direct	F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $5.055 - $5.27. The reporting person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
F2	25% of the shares vested on the 12 month anniversary of the vesting commencement date of June 17, 2019, and the balance of the shares vest in a series of 36 successive equal monthly installments measured from the 12 month anniversary of the vesting commencement date.
F3	25% of the shares vested on the 12 month anniversary of the vesting commencement date of December 5, 2019, and the balance of the shares vest in a series of 36 successive equal monthly installments measured from the 12 month anniversary of the vesting commencement date.
F4	1/48 of the shares subject to the Stock Option vest when the Reporting Person completes each month of continuous service beginning February 12, 2020.